These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11594687)

  • 1. Structural studies of chemokines that inhibit HIV-1 entry.
    Fernandez EJ; Lolis E
    Antivir Chem Chemother; 2001; 12 Suppl 1():43-9. PubMed ID: 11594687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
    Zhou N; Luo Z; Luo J; Liu D; Hall JW; Pomerantz RJ; Huang Z
    J Biol Chem; 2001 Nov; 276(46):42826-33. PubMed ID: 11551942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure and structural mechanism of a novel anti-human immunodeficiency virus and D-amino acid-containing chemokine.
    Liu D; Madani N; Li Y; Cao R; Choi WT; Kawatkar SP; Lim MY; Kumar S; Dong CZ; Wang J; Russell JD; Lefebure CR; An J; Wilson S; Gao YG; Pallansch LA; Sodroski JG; Huang Z
    J Virol; 2007 Oct; 81(20):11489-98. PubMed ID: 17686848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
    J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
    Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
    Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
    Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA
    Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
    Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
    J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages.
    Stantchev TS; Broder CC
    J Infect Dis; 2000 Jul; 182(1):68-78. PubMed ID: 10882583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of the anti-HIV chemokine vMIP-II.
    Liwang AC; Wang ZX; Sun Y; Peiper SC; Liwang PJ
    Protein Sci; 1999 Nov; 8(11):2270-80. PubMed ID: 10595530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
    Howard OM; Oppenheim JJ; Hollingshead MG; Covey JM; Bigelow J; McCormack JJ; Buckheit RW; Clanton DJ; Turpin JA; Rice WG
    J Med Chem; 1998 Jun; 41(13):2184-93. PubMed ID: 9632350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction.
    Grainger DJ; Lever AM
    Retrovirology; 2005 Apr; 2():23. PubMed ID: 15807900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 entry into cells.
    Copeland KF
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):107-12. PubMed ID: 18221139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
    Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
    J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
    Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
    J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.